Literature DB >> 1469094

Pleiotropic effects of antithrombin strand 1C substitution mutations.

D A Lane1, R J Olds, J Conard, M Boisclair, S C Bock, M Hultin, U Abildgaard, H Ireland, E Thompson, G Sas.   

Abstract

Six different substitution mutations were identified in four different amino acid residues of antithrombin strand 1C and the polypeptide leading into strand 4B (F402S, F402C, F402L, A404T, N405K, and P407T), and are responsible for functional antithrombin deficiency in seven independently ascertained kindreds (Rosny, Torino, Maisons-Laffitte, Paris 3, La Rochelle, Budapest 5, and Oslo) affected by venous thromboembolic disease. In all seven families, variant antithrombins with heparin-binding abnormalities were detected by crossed immunoelectrophoresis, and in six of the kindreds there was a reduced antigen concentration of plasma antithrombin. Two of the variant antithrombins, Rosny and Torino, were purified by heparin-Sepharose and immunoaffinity chromatography, and shown to have greatly reduced heparin cofactor and progressive inhibitor activities in vitro. The defective interactions of these mutants with thrombin may result from proximity of s1C to the reactive site, while reduced circulating levels may be related to s1C proximity to highly conserved internal beta strands, which contain elements proposed to influence serpin turnover and intracellular degradation. In contrast, s1C is spatially distant to the positively charged surface which forms the heparin binding site of antithrombin; altered heparin binding properties of s1C variants may therefore reflect conformational linkage between the reactive site and heparin binding regions of the molecule. This work demonstrates that point mutations in and immediately adjacent to strand 1C have multiple, or pleiotropic, effects on this serpin, leading ultimately to failure of its regulatory function.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1469094      PMCID: PMC443398          DOI: 10.1172/JCI116133

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  63 in total

1.  INHERITED ANTITHROMBIN DEFICIENCY CAUSING THROMBOPHILIA.

Authors:  O EGEBERG
Journal:  Thromb Diath Haemorrh       Date:  1965-06-15

2.  Antithrombin III Basel. Identification of a Pro-Leu substitution in a hereditary abnormal antithrombin with impaired heparin cofactor activity.

Authors:  J Y Chang; T H Tran
Journal:  J Biol Chem       Date:  1986-01-25       Impact factor: 5.157

3.  Molecular heterogeneity of inherited antithrombin III deficiency.

Authors:  E V Prochownik; S Antonarakis; K A Bauer; R D Rosenberg; E R Fearon; S H Orkin
Journal:  N Engl J Med       Date:  1983-06-30       Impact factor: 91.245

4.  Proposed heparin binding site in antithrombin based on arginine 47. A new variant Rouen-II, 47 Arg to Ser.

Authors:  J Y Borg; M C Owen; C Soria; J Soria; J Caen; R W Carrell
Journal:  J Clin Invest       Date:  1988-04       Impact factor: 14.808

5.  Heterogeneity of the "classical" antithrombin III deficiency.

Authors:  G Sas; I Petö; D Bánhegyi; G Blaskó; G Domján
Journal:  Thromb Haemost       Date:  1980-06-18       Impact factor: 5.249

6.  Hereditary antithrombin III deficiency: biochemical aspects.

Authors:  G Sas
Journal:  Haematologia (Budap)       Date:  1984

7.  Antithrombin-III-Hamilton: a gene with a point mutation (guanine to adenine) in codon 382 causing impaired serine protease reactivity.

Authors:  R Devraj-Kizuk; D H Chui; E V Prochownik; C J Carter; F A Ofosu; M A Blajchman
Journal:  Blood       Date:  1988-11       Impact factor: 22.113

8.  Antithrombin Milano, single amino acid substitution at the reactive site, Arg393 to Cys.

Authors:  H Erdjument; D A Lane; H Ireland; V Di Marzo; M Panico; H R Morris; A Tripodi; P M Mannucci
Journal:  Thromb Haemost       Date:  1988-12-22       Impact factor: 5.249

9.  Heparin binding defect in a new antithrombin III variant: Rouen, 47 Arg to His.

Authors:  M C Owen; J Y Borg; C Soria; J Soria; J Caen; R W Carrell
Journal:  Blood       Date:  1987-05       Impact factor: 22.113

10.  Alpha 2-antiplasmin Enschede is not an inhibitor, but a substrate, of plasmin.

Authors:  D C Rijken; E Groeneveld; C Kluft; H K Nieuwenhuis
Journal:  Biochem J       Date:  1988-10-15       Impact factor: 3.857

View more
  13 in total

1.  The role of strand 1 of the C beta-sheet in the structure and function of alpha(1)-antitrypsin.

Authors:  S P Bottomley; I D Lawrenson; D Tew; W Dai; J C Whisstock; R N Pike
Journal:  Protein Sci       Date:  2001-12       Impact factor: 6.725

Review 2.  Inherited thrombophilia: memorandum from a joint WHO/International Society on Thrombosis and Haemostasis meeting.

Authors: 
Journal:  Bull World Health Organ       Date:  1997       Impact factor: 9.408

3.  Exhaustive mutation scanning by fluorescence-assisted mismatch analysis discloses new genotype-phenotype correlations in angiodema.

Authors:  E Verpy; M Biasotto; M Brai; G Misiano; T Meo; M Tosi
Journal:  Am J Hum Genet       Date:  1996-08       Impact factor: 11.025

4.  Antithrombin Murcia (K241E) causing antithrombin deficiency: a possible role for altered glycosylation.

Authors:  Irene Martínez-Martínez; Adriana Ordóñez; José Navarro-Fernández; Angel Pérez-Lara; Ricardo Gutiérrez-Gallego; Rafael Giraldo; Constantino Martínez; Esther Llop; Vicente Vicente; Javier Corral
Journal:  Haematologica       Date:  2010-04-30       Impact factor: 9.941

5.  Disease-causing mutations in the serpin antithrombin reveal a key domain critical for inhibiting protease activities.

Authors:  Sonia Águila; Gonzalo Izaguirre; Irene Martínez-Martínez; Vicente Vicente; Steven T Olson; Javier Corral
Journal:  J Biol Chem       Date:  2017-07-25       Impact factor: 5.157

6.  Five novel and four recurrent point mutations in the antithrombin gene causing venous thrombosis.

Authors:  Keiko Nagaizumi; Hiroshi Inaba; Kagehiro Amano; Midori Suzuki; Morio Arai; Katsuyuki Fukutake
Journal:  Int J Hematol       Date:  2003-07       Impact factor: 2.490

7.  Antithrombin III: summary of first database update.

Authors:  D A Lane; R J Olds; S L Thein
Journal:  Nucleic Acids Res       Date:  1994-09       Impact factor: 16.971

8.  Crucial residues in the carboxy-terminal end of C1 inhibitor revealed by pathogenic mutants impaired in secretion or function.

Authors:  E Verpy; E Couture-Tosi; E Eldering; M Lopez-Trascasa; P Späth; T Meo; M Tosi
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

9.  Cellular folding pathway of a metastable serpin.

Authors:  Kshama Chandrasekhar; Haiping Ke; Ning Wang; Theresa Goodwin; Lila M Gierasch; Anne Gershenson; Daniel N Hebert
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-24       Impact factor: 11.205

10.  Specific interactions of serpins in their native forms attenuate their conformational transitions.

Authors:  Yu-Ran Na; Hana Im
Journal:  Protein Sci       Date:  2007-06-28       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.